ANIKA THERAPEUTICS, INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1992-01-01
- Employees
- 357
- Market Cap
- -
- Website
- http://www.anika.com
Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide
- Conditions
- Knee Osteoarthritis
- Interventions
- First Posted Date
- 2017-06-19
- Last Posted Date
- 2022-02-24
- Lead Sponsor
- Anika Therapeutics, Inc.
- Target Recruit Count
- 576
- Registration Number
- NCT03191903
- Locations
- 🇵🇱
NZOZ Medi SPATZ, Gliwice, Poland
🇵🇱ETG Network, Warsaw, Warsaw, Poland
🇭🇺Baleseti Központ, Budapest,, Hungary
Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow)
- Conditions
- EpicondylosisEpicondylitisTennis Elbow
- Interventions
- Device: SalineDevice: OVT (Sodium Hyaluronate)
- First Posted Date
- 2016-08-10
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Anika Therapeutics, Inc.
- Registration Number
- NCT02861183
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
- Conditions
- Defect of Articular Cartilage
- Interventions
- Device: HyalofastProcedure: Microfracture
- First Posted Date
- 2016-01-20
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Anika Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT02659215
- Locations
- 🇺🇸
Axis Clinical Trials, Los Angeles, California, United States
🇺🇸Kerlan-Jobe Orthopedic Clinic, Los Angeles, California, United States
🇺🇸BioSolutions Clinical Research Center, San Diego, California, United States
Repeat Injection of Cingal® for Osteoarthritis of the Knee
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Combination Product: Cingal
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Anika Therapeutics, Inc.
- Target Recruit Count
- 242
- Registration Number
- NCT02381652
- Locations
- 🇨🇿
Medical Plus s.r.o., Uherske Hradiste, Czechia
🇭🇺Jutrix Healthcare Services Ltd., Kecskemet, Hungary
🇵🇱NZOZ Medi-Spatz, Gliwice, Poland
Cingal Study for Knee Osteoarthritis
- Conditions
- Knee Osteoarthritis
- Interventions
- Device: Hyaluronic Acid and TH (Cingal®)Device: SalineDevice: Hyaluronic Acid (Monovisc®)
- First Posted Date
- 2013-07-03
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Anika Therapeutics, Inc.
- Target Recruit Count
- 368
- Registration Number
- NCT01891396
- Locations
- 🇧🇬
Clinic of Orthopaedics and Traumatology, University Multiprofile Hospital for Active Treatment "Tsaritsa Yoanna", Sofia, Bulgaria
🇧🇬Orthopaedics Clinic Multiprofile Hospital for Active Treatment "Sveti Georgi", Plovdiv, Bulgaria
🇧🇬Consultative Outpatients' Medical Office for Rheumatologic Diseases, Sofia, Bulgaria
Safety Study of Cosmetic Tissue Augmentation in People of Color
- Conditions
- Wrinkles
- Interventions
- Device: Elevess
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2017-10-17
- Lead Sponsor
- Anika Therapeutics, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT01147172
- Locations
- 🇺🇸
Vitiligo and Pigmentation Inst of Southern California, Los Angeles, California, United States
🇺🇸International Dermatology Research, Miami, Florida, United States
🇺🇸Skin Care Research, Inc., Boca Raton, Florida, United States
Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee
- Conditions
- Osteoarthritis
- Interventions
- Device: Monovisc®Other: Saline
- First Posted Date
- 2008-04-07
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Anika Therapeutics, Inc.
- Target Recruit Count
- 369
- Registration Number
- NCT00653432
- Locations
- 🇺🇸
Novara Clinical Research, Mesa, Arizona, United States
🇺🇸Intermountain Research Center, Boise, Idaho, United States
🇺🇸Physician Research Collaboration, Lincoln, Nebraska, United States